Clinical Trials · NCT05813925
A Research Study to See How Well CagriSema Helps People in East Asia With Excess Body Weight Lose Weight
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 331
- Start date
- Apr 2023
- Locations
- 28 sites, Japan, Taiwan
- Primary endpoint
- Relative Change in Body Weight